Trial
NCT03952481
Effect of Lifitegrast 5% on Tear Film Markers
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Weill Medical College of Cornell University
Collaborators
Novartis
Condition
Dry Eye
Intervention
Lifitegrast 5% Ophthalmic Solution
Why stopped
COVID restrictions
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-16